chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Information has been received from a physician concerning a 6 year old female patient with no pertinent medical history and no known allergies who on an unspecified date was vaccinated with the second 0.5 ml dose of VARIVAX (Merck) (lot number not reported). There was no concomitant medication. In mid January, 2010 the patient come back in the office with a very mild chickenpox like rash around the head and shoulder area. The physician stated she asked the patient to call back in a couple days with an update but the patient never did so the physician was unsure of the patient's status at this point. There was no lab studies performed. Additional information has been requested.
Age: 59.0
Sex: M
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a physician and an office administrator concerning an approximately 59 year old male patient who was indicated for ZOSTAVAX (Merck) in 2008 and was vaccinated with 2 doses of VARIVAX (Merck) (lot number not reported) mistakenly by the provider (dates unspecified).  The physician confirmed that he administered VARIVAX (Merck) according to the prescribing information interval.  There were no adverse effects reported.  Unspecified medical attention was sought.  At the time of the report, the outcome of the patient was not reported.  Follow-up information has been received from an office administrator who reported that she did not have the lot number.  This is one of several reports from the same source.  Additional information has been requested.
Age: 61.0
Sex: M
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a nurse concerning a 61 year old male who on 16-JUL-2009 was vaccinated with a dose of VARIVAX (Merck) (lot # was reported as 1739) instead of ZOSTAVAX (Merck) in his left arm.  Human error.  No adverse effect noted.  At the report time the outcome was unknown.  No further information is available.
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a male nurse who "12 years ago", in February 1998, was vaccinated with a dose of VARIVAX (Merck) (dose, route and lot # not reported).  The physician reported that the patient developed varicella after receiving VARIVAX (Merck).  The patient's outcome was unknown.  It was unknown if the patient sought medical attention.  No further information is available.
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a nurse practitioner concerning a 9 year old female student who was vaccinated with the second dose of VARIVAX (Merck) (Lot# 664712/0799Y). The patient developed a red raised area the size of softball at the site of injection. Follow-up information received from a nurse indicated that a 9 year old female student with no known drug allergy who was vaccinated SC with the first dose of VARIVAX (Merck) (Lot# 664025/0844Y) at right arm. On 15-AUG-2009 at 13:57pm the patient experienced injection site red and swollen. The patient had not sought medical attention. At the time of the report the patient's status was unknown. This is one of several reports from the same source. Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Urticaria
Clinical narrative: Information has been received from a nurse concerning a patient who on 06-JUL-2009 was vaccinated with the second 0.5 ml dose of VARIVAX (Merck) (subcutaneous injection) (lot # 663541/0335Y) and a dose of MMR II (MSD) (lot#, dose, route not reported).  On 06-JUL-2009 the patient experienced swelling and redness at the injection site as well as hives later that day.  The patient was seen in the office on 08-JUL-2009 but it was unknown if therapy was prescribed.  The patient called the office on 09-JUL-2009 and stated the symptoms were getting worse.  No lab diagnostics studies were performed.  At the time of reporting, the patient had not recovered.  The nurse mentioned that 6 other patients, who all received VARIVAX (Merck) as a second dose, had reported similar symptoms.  The nurse was requesting a lot check.  Follow up information has been received from the same nurse concerning a 12-13 year old female patient who on 06-JUL-2009 was vaccinated with a second 0.5 ml dose of VARIVAX (Merck) (subcutaneous injection) (lot # 663541/0335Y).  The nurse reported the patient had not had any ore since vaccination, and all that reacted had recovered.  A lot check has been initiated.  A standard lot check investigation was performed for VARIVAX (Merck) (lot # 663541/0335Y).  All in-process quality checks for the lot number in question were satisfactory.  The lot met the requirements of the Center of Biologics Evaluation and Research and was released.  This is one of several reports received from the same source.  Additional information has been requested.
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Vaccination complication
Clinical narrative: Information has been received from a consumer concerning her 3 year old male grandson who "had a bad reaction to amoxicillin" and on an unspecified date was vaccinated with a dose of VARIVAX (manufacturer unspecified). It was reported that the patient "had a reaction" to the VARIVAX (manufacturer unspecified). The patient sought unspecified medical attention. At the time of the report the patient's outcome was not specified. No further information is available.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a company representative concerning her 4 year old son who was vaccinated with only one dose of VARIVAX (Merck) (lot#, route and site of administration not reported). On 07-JUL-2009 the patient had an outbreak of chickenpox with 4 lesions. At the time of reporting the patient's outcome was unknown. This is one of several reports from the same source. Additional information has been requested.
Age: 13.0
Sex: U
Vaccine: HEPA, VARCEL
Symptoms: Cellulitis, Pallor
Clinical narrative: Information has been received from a nurse concerning a 13 year old patient with a history of hepatitis a who on 20-JUL-2009 was vaccinated with a second dose of VARIVAX (Merck) (lot # 662118/0380Y) 0.5ml. Suspect secondary therapy included hepatitis A virus vaccine. On 20-JUL-2009 after getting the vaccine the patient experienced blanching and cellulitis. On 22-JUL-2009 the patient was seen in the office. On unspecified date the patient recovered. This is one of three reports from the same source. Follow up information has been received on 20-OCT-2009 via telephone call from a nurse who reported the patient experienced cellulitis previously reported as cellulites. No further information is available.
Age: 12.0
Sex: F
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Incorrect route of drug administration, Injection site pain
Clinical narrative: Information has been received from a nurse concerning her 12 year old daughter with no medical history and no allergy who on 17-JUL-2009 was vaccinated intramuscularly with the second 0.5mL dose of VARIVAX (Merck) (LOT# 661997/1388X). Concomitant vaccinations given on the same day included a dose of Tdap and a dose of MENACTRA. On 17-JUL-2009, at the time of vaccination, the patient felt little pain and sting at the injection site. She was sought unspecified medical attention and recovered on the same day. The first dose was received on 27-AUG-1997. Follow-up information has been received from the nurse concerning the 12 (also reported as 13) year old patient who on 17-JUL-2009 in the afternoon received the second 0.5mL dose of VARIVAX (Merck) (LOT# 661997/1388X). The reporter stated that it was a medication error because it was given "IM" instead of subcutaneous. It was not adverse reaction. No further information is available.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 12 year old female patient with no drug reactions/allergies who on 04-JAN-1999 was vaccinated with a first 0.5 mL dose of VARIVAX (Merck) (Lot # not reported).  There was no concomitant medication.  On 13-MAY-2009 the patient developed classic varicella after getting the first dose of VARIVAX (Merck).  The patient sought unspecified medical attention.  There were no laboratory or diagnostic tests performed.  On an unspecified date, the patient recovered.  No further information is available.
Age: 9.0
Sex: F
Vaccine: FLUN(H1N1), VARCEL
Symptoms: Incorrect route of drug administration, Injection site cellulitis
Clinical narrative: Information has been received from a physician's assistant concerning a 9 year old white female with no known drug allergies and no illness at the time of vaccination who on 17-FEB-2010 was vaccinated with intramuscularly into the left arm with second dose of VARIVAX vaccine (Merck) (dose not reported, lot number 664616/0971Y). Concomitant vaccination administered on the same date included Influenza A H1N1 vaccine (cold adapted Ann Arbor master strain) (route nasal, lot number 5008499). On 18-FEB-2010 at 06:00 p.m., the patient developed injection site cellulitis the next day after receiving VARIVAX (Merck). It was reported that the patient required a doctor visit. The final outcome was not reported. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Body temperature increased, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 4 year old female with no pertinent medical history or allergies who on 28-OCT-2008 was vaccinated subcutaneously with a second 0.5ml dose of VARIVAX (Merck) (lot# 661444/0529X). There was no concomitant medication. On 16-JUL-2009 the patient developed a mild case of chickenpox. She visited the office and the physician prescribed acyclovir to her. No lab diagnostics studies were performed. At the time of reporting the patient was not recovered. Follow up information has been received from the registered nurse concerning the 4 year old female child with no pre-existing allergies, birth defects or medical conditions who on 18-OCT-2005 was vaccinated subcutaneously with the first dose of VARIVAX (Merck) (lot# 661444/0529X) into the left arm and the first dose of MMR II (lot# 658156/0215X) into the right arm. Concomitant therapy included DTAP (lot # C2957AA, schedule: 21-DEC-2004, 08-DEC-2005, 12-APR-2005, 10-APR-2006) IM into the right arm and IPV (lot#A1060, schedule: 21-DEC-2004, 08-FEB-2005, 10-APR-2006) IM into the left arm. On 17-JUL-2009 the patient came into the physician's office with rash and low-grade fever. She was diagnosed with chickenpox and the illness was mild. The patient was treated with acyclovir, 200mg/5ml; sig: 400mg, oral administration, q8 hours for 4 days. There was no illness at the time of vaccination. No relevant diagnostic tests were performed. At the time of this report, the patient's outcome was unknown. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician assistant concerning "approximately 12 month old" male patient who on approximately 09-JUL-2009 was vaccinated with a dose of VARIVAX (Merck) (lot # not reported). On 22-JUL-2009 physician assistant friend went to her office and brought along her infant son and showed her that the infant had a mosquito bite. Physician assistant saw that the bite looked like chickenpox and she recommended her friend to bring the infant back to her pediatrician. To have it checked. Follow up information received on 01-SEP-2009 from the physician's assistant indicated that she does not had any additional information regarding this case as he was not her patient. The patient was lost to follow up. Follow-up information was received from the physician's assistant indicating that she had no knowledge of the patient except that he was okay. No further information is available.
Age: 42.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site nodule, Injection site reaction
Clinical narrative: Information has been received from a medical assistant concerning a 42 year old female with SEPTRA allergy and no pertinent medical history who on 19-JUN-2009 was vaccinates subcutaneously with the first 0.5ml dose of VARIVAX (Merck) (lot# 663709/0193Y). Concomitant therapy included trazodone HCl, thyroid medication, birth control pills and anti-inflammatory medications. On 21-JUN-2009 ("two days after vaccination") the patient developed injection site reaction. The patient had the raised "knot" the size of a quarter and the injection site redness was the size of "50 cents". No medical attention was sought. The reaction lasted about 4 days. On approximately 25-JUN-2009 the patient recovered. No further information is available.
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Inappropriate schedule of drug administration, Injection site urticaria
Clinical narrative: Information has been received from a physician concerning a 11 month old male patient who on 25-FEB-2010 was vaccinated with the first 0.5 mL dose of VARIVAX (Merck). Concomitant was vaccinated with MMR II (MSD) and VAQTA (inactive) (manufacturer unknown) on same day but on different arm. The physician reported that on 25-FEB-2010, the patient developed 1 cm hives at the injection sire where VARIVAX (Merck) was administered. At the time of the report, the patient was recovering. Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: VARCEL
Symptoms: Antineutrophil cytoplasmic antibody negative, No therapeutic response, Seroconversion test negative
Clinical narrative: Information has been received from a pharmacist concerning a 17 year old female who in 1998 was vaccinated with the first dose of VARIVAX (Merck). In 2007 the patient received the second dose of VARIVAX (Merck). On an unspecified date the patient had titers drawn showing that she failed to seroconvert. No adverse effects noted. At the report time the outcome was unknown. Additional information has been requested.
Age: 1.08
Sex: M
Vaccine: HEPA, MMR, PNC, VARCEL
Symptoms: Pyrexia, Varicella post vaccine
Clinical narrative: Initial and follow-up information has been received from a licensed practical nurse concerning a 13 month old male patient with no drug allergies or medical history who on 13-JUL-2009 was vaccinated with a dose of VARIVAX (Merck) (lot# 664468/0684Y). Secondary suspect vaccination administered on the same day included MMR II (MSD) (duration and dose not reported). On 22-JUL-2009 evening, the patient developed a full blown case of chickenpox. The child was covered in more than 75 lesions and had a fever. The patient was seen in the office on 23-JUL-2009 but no medication prescribed. Only "symptomatic treatment" recommended. No lab diagnostics studies were performed. At the time of the report, the patient had not recovered. Follow-up information has been received from a licensed vocational nurse concerning a 13 month old (also reported as 14 month old) male patient with Atopic Dermatitis at time of vaccination and no pre-existing allergies or medical history who on 13-JUL-2009 was vaccinated with a first dose of VARIVAX (Merck) SQ into the right arm at 11:20am. Secondary suspect vaccinations administered on the same day at 11:20 AM included the first dose of MMR II (MSD, lot#663165/1640X) SQ into the left arm and the first dose of VAQTA (MSD, lot#663683/1715X) IM into the right leg. Other concomitant vaccination on the same day at 11:20 AM included the fourth dose of PREVNAR (Lederle, lot#D63486) IM in the left leg. Subsequently, during the night time on 22-JUL-2009, the patient developed a rash. The patient had an ill appearing, non toxic, moderate amount of varicella exanthema on his trunk, which was greater than 75. On 23-Jul-2009 the patient visited the doctor's office. No lab diagnostic tests were performed. At the time of the report, the patient recovered on an unspecified date. This is one of several reports from the same source. Additional information is not expected.
Sex: F
Vaccine: VARCEL
Symptoms: Injection site rash, Injection site vesicles
Clinical narrative: Information has been received from a physician assistant concerning a female who on 01-JUL-2009 was vaccinated with a dose of VARIVAX (Merck) (lot # 664502/0687Y).  Subsequently the patient developed a blistery rash at the injection site.  The patient has sought medical attention via office visit..   Additional information has been requested.
Age: 3.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician through company representative concerning a "now 10 or 11 year old" female who at approximately 3 year of age was vaccinated with the first 0.5 mL dose of VARIVAX (Merck) (route and Lot# not reported).  The patient developed chicken pox at 3 years of age after getting the first dose of VARIVAX (Merck).  So physician decided not to give the patient the second dose.  Recently, the patient developed a case of chicken pox again.  Unspecified medical attention was sought.  At this time of reporting, the patient was not recovered. Additional information has been requested.
Age: 1.02
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a nurse concerning a 10 year old male who on 23-FEB-2000 was vaccinated with the first dose of VARIVAX (Merck) (LOT# 632056/1449J). The nurse noted that the patient received the second dose on an unspecified date. On 14-JUL-2009 the patient developed chicken pox. The patient was seen by a nurse and no outcome was provided. No other information is available at the time of this report. Additional information has been requested.
Age: 3.0
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a camp physician concerning a 10 years old patient who on 16-MAY-2002 was vaccinated with a dose of VARICELLA (Merck) (lot# 643078/0471M). On 17-JUL-2009 the patient had a chickenpox outbreak. The patient had seen the camp physician for medical attention. The reporter was concerned that the lot number of VARIVAX (Merck) that was given tot his child may have been ineffective. The patient is currently recovering. A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Secondary transmission
Clinical narrative: Information has been received from a company representative, concerning her sister-in-law who mentioned that a few years ago she developed zoster right after both her children were vaccinated with VARIVAX (Merck).  The zoster lasted for about six weeks, and the patient was completely recovered now.  Additional information has been requested.
Age: 10.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Injection site pruritus, Injection site swelling
Clinical narrative: Information has been received from a physician concerning a 10 year old male with a history of hepatitis A, who on 22-JUL-2009 was vaccinated with his 2nd dose of VARIVAX (Merck) (lot # 664506/0688Y), 0.5ml. Concomitant therapy included VAQTA (MSD). On 22-JUL-2009 the patient experienced itching and swelling at the injection site. There were no labs and diagnostic tests performed. The patient had sought unspecified medical attention. At the time of the report, the patient's status was unknown. Follow up information has been received indicating that they cannot find the patient's chart because they do not know the patient's name. No further information is available.
Age: 1.8
Sex: M
Vaccine: VARCEL
Symptoms: Inappropriate schedule of drug administration, Pyrexia, Rhinorrhoea
Clinical narrative: Information has been received from a physician concerning her 21 month old male son who on 27-JUL-2009 (also reported as 26-JUL-2009) and on 02-OCT-2009 was vaccinated with the first and second doses respectively of VARIVAX (Merck) (route and lot # unknown).  Concomitant therapy included DTAP on 02-OCT-2009.  The physician was concerned because not 3 months apart but her physician said that the initial dose in July did not count, "unknown why".  The physician said that beginning on 02-OCT-2009 her son had a fever and runny nose.  The patient sought medical attention at the physician office.  At the time of this report the patient's outcome was not recovered.  Follow-up information was received from a physician via pediatric medical records concerning the 21 month old patient with no pre-existing allergies, birth defects or medical conditions, who on 29-JUL-2009 at 14:30 (previously reported as 27-JUL-2009 and 26-JUL-2009), received a first dose of VARIVAX (Merck) (lot # 65898/1338U) subcutaneously into his right thigh, and concomitantly received a dose of PCV (unspecified) (manufacturer unspecified).  On 01-OCT-2009 at 14:23 (previously reported as 02-OCT-2009), the patient received the second dose of VARIVAX (Merck) (lot # 664725/0861Y) subcutaneously into his right thigh, and concomitantly received a dose of DTAP (manufacturer unspecified), IM into his left thigh.  There was no illness at time of vaccination.  It was reported by the physician that the patient's first dose of VARIVAX (Merck) was given within 30 days of previous vaccines MMR II (unspecified) and Hep A (manufacturer unspecified) (both given on 07-JUL-2009).  This was considered "not valid".  Due to the VARIVAX (Merck) being a "live virus", the patient was very far behind on his vaccines.  The physician reported that the VARIVAX (Merck) needed to be repeated.  There were no ordered tests and laboratory data.  No further information is available.
Age: 75.0
Sex: M
Vaccine: VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a pharmacist concerning a patient who on 21-JUL-2009 was inadvertently vaccinated with VARIVAX (Merck). It was reported that the patient was suppose to get ZOSTAVAX (Merck). No adverse effect was reported. Follow up information has been received from a physician's assistant concerning the 75 year old retired male who in the morning of 21-JUL-2009 was vaccinated with the first dose of VARIVAX (Merck) (lot# 662470/0041Y, route not reported) into the left arm. There was no illness at time of vaccination. No relevant laboratory test was performed. No adverse reaction was reported. Additional information is not expected.
Age: 86.0
Sex: F
Vaccine: VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a Physician, concerning an 86 year old female patient with hypertension, depression, elevated lipids, anxiety and allergy to aspirin, who on 26-FEB-2010 was vaccinated with a dose of VARIVAX (dose not reported) (lot number 665180/1133Y). Concomitant therapy included Alprazolam, Hydrocodone, Sertraline HCl, Propranolol HCl and vitamin D (unspecified). It was reported that on 26-FEB-2010. The Medical Assistant administered to patient VARIVAX instead of ZOSTAVAX by mistake. At the time of reporting, no adverse effects occurred. Follow-up information has been received from a Medical Assistant, who stated that the VARIVAX and the ZOSTAVAX were stored closely together in the same refrigerator. The Medical Assistant also stated that the Nurse administered the VARIVAX due to medication error. The office had a plan to correct the vaccine storage situation. Additional information is not expected.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular, Skin lesion
Clinical narrative: Information has been received from a physician concerning her 12 month old daughter who on an unspecified date was vaccinated with the first dose of VARIVAX (Merck). The physician reported that 5 days after vaccination her daughter had generalized varicella like rash on her upper chest and arm about 15 lesions. On an unspecified date the patient recovered. The patient sought medical attention. Additional information has been requested.
Age: 67.0
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a nurse concerning a 67 year old patient who on 21-JUL-2009 was vaccinated with a dose of VARIVAX (Merck) (0.5ml, SQ) instead of ZOSTAVAX (Merck). The reporter stated that this was staff error, not product confusion. No adverse effect reported. At the report time the outcome was unknown. Additional information has been requested.
Age: 16.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 16 year old female patient who on an unspecified date was vaccinated with the second dose of VARIVAX (Merck) (lot number not reported). "A month and half ago", on approximately 11-JAN-2010 the patient experienced chickenpox. It was unknown if medical attention was sought. The outcome of the patient was not reported. The physician was the treating physician not the prescribing physician. Additional information has been requested.
Age: 1.54
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a licensed practical nurse concerning a approximately 9 year old patient who on 29-JUN-1998 was vaccinated with VARIVAX (Merck). On approximately 11-OCT-2006, the patient experienced approximately 50 lesions. At the time of the report, the patients' outcome was unknown. This is one of several reports received from the same source. No further information is available.
Age: 34.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a consumer concerning her currently 43 year old daughter with a history of "had her gallbladder out, sinus problems and pneumonia" and allergic to codeine who at "sometimes in the 1990's was vaccinated with a dose of VARIVAX (Merck) (lot#, route and site of administration not reported). In the late 90's the patient developed shingles. She went to see her physician for treatment. Then again sometime in 2001-2003 the patient developed another shingles case. It was reported that the patient never had a history of chickenpox. She saw her physician for treatment and on an unspecified date she recovered. No further information is available.
Sex: F
Vaccine: VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a physician concerning a female with a history of chickenpox who in December 2007, was vaccinated with a dose of VARIVAX (Merck) instead of ZOSTAVAX (Merck). No adverse reactions reported. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a physician concerning unspecified number of patients who were inadvertently vaccinated with VARIVAX (Merck) instead of shingles vaccine. Follow-up information has been received from a office manager of a physician's office who reported that there were 4-6 elderly patients who were given the wrong vaccine. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available. Additional information has been requested.
Age: 1.02
Sex: M
Vaccine: VARCEL
Symptoms: Pyrexia, Rash vesicular
Clinical narrative: Information has been received from a consumer concerning her 12 month old son with no pertinent medical history and no drug reactions who on 05-OCT-2009 was vaccinated with a dose of VARIVAX (Merck) (lot#, route and site of administration not reported). There was no concomitant medication. On 05-OCT-2009 the patient developed a low grade fever and varicella like pumps on his back, torso, neck and skull after vaccination. The patient did not seek medical attention and there were no laboratory diagnostics studies performed. At the time of this report, the patient had not recovered. No further information is available.
Age: 16.0
Sex: U
Vaccine: VARCEL
Symptoms: Cellulitis, Pallor
Clinical narrative: Information has been received from a nurse concerning a 16 year old patient with a history of hepatitis A who on 27-JUL-2009 was vaccinated with a second dose of VARIVAX (Merck) (lot # 664692/0694Y) 0.5ml. Suspect secondary therapy include VAQTA (MSD). On 27-JUL-2009 after getting the vaccine the patient experienced blanching and cellulites. On 28-JUL-2009 the patient was seen in the office. On unspecified date the patient recovered. This is one of three reports from the same source. Follow up information has been received on 20-OCT-2009 via telephone call from a registered nurse who reported that the patient experienced cellulitis previously reported as cellulites. No further information is available.
Age: 11.0
Sex: M
Vaccine: VARCEL
Symptoms: Chest discomfort, Chest pain, Pharyngeal oedema
Clinical narrative: Information has been received from a consumer concerning her 11 year old son with allergies to egg, peanuts and tree nuts who on 14-SEP-2009 was vaccinated with a 0.5ml dose of VARIVAX (Merck) (lot#, route and site of administration not reported). There was no concomitant medication. On 14-SEP-2009, several hours later, the patient experienced chest pain and felt like someone was sitting on his chest. A few hours after that, his throat started swelling. Medical attention was sought and he was given BENADRYL (manufacturer unknown) and was fine. There were no laboratory diagnostic studies performed. On 14-SEP-2009 the patient recovered. No further information is available.
Age: 0.34
Sex: U
Vaccine: VARCEL
Symptoms: Inappropriate schedule of drug administration, Varicella post vaccine
Clinical narrative: Information has been received from a licensed practical nurse concerning a 7 year old patient who in 2002 was vaccinated with a dose of VARIVAX (Merck).  In May 2009, the patient developed a chickenpox outbreak.  Subsequently, the patient recovered from chickenpox on an unspecified date.  Additional information has been requested.
Age: 59.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Inappropriate schedule of drug administration
Clinical narrative: Information has been received from a physician concerning a 59 year old male who on 18-AUG-2009 was vaccinated with ZOSTAVAX (Merck). No concomitant medication, drug reactions/allergies or medical history were reported. On an unspecified date the patient experienced an outbreak of shingles after administration of ZOSTAVAX (Merck). He was examined in the emergency department on 17-SEP-2009 completing a course of acyclovir. He was not admitted and released with an additional prescription of acyclovir. He was administered a second dose of VARIVAX (Merck) on 08-DEC-2009. No lab diagnostic studies were performed. On an unspecified date the patient recovered from outbreak of shingles. All telephone attempts to obtain follow-up information have been unsuccessful. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a nurse concerning a female "in her teens" who on an unspecified date was vaccinated with a dose of VARIVAX (Merck) (dose, route and lot number not reported). About a month ago, in approximately June 2009, "after receiving the vaccine, the patient developed a rash". The patient recovered from rash on an unspecified date. It was not specified if the patient sought medical attention. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Erythema, Skin warm, Swelling
Clinical narrative: Information has been received from a physician concerning a 5 year old male patient who on 19-AUG-2009, was vaccinated with the second dose of VARIVAX (Merck) (lot# 664717/0807Y) in the right thigh. On 20-AUG-2009, the patient experienced redness, swelling and warm to touch. At the time of the report the patient had recovered. It is unknown if the patient sought medical attention. This is one of two reports from the same source. Additional information is not expected.
Age: 63.0
Sex: M
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a 63 year old male consumer with herpes simplex who about two months ago, was vaccinated with a 0.5 mL first dose of VARIVAX (Merck). The patient received a 0.5 mL second dose of VARIVAX (Merck) on an unspecified date. Concomitant therapy included acyclovir. A month later the patient had a titer test done and it came back negative. At the time of this report the patient had not recovered. The patient sought unspecified medical attention. Additional information is not expected.
Age: 1.06
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a Licensed Visiting Nurse (L.V.N.) concerning an 8 year old male patient with shellfish allergy, fish allergy, hypersensitivity, attention deficit/hyperactivity disorder and history of asthma who on 21-JUL-2002, at age one year and one month, was vaccinated with a dose of VARIVAX (Merck). It was reported that on 27-JUN-2009 the patient was diagnosed with shingles on his right leg. He was prescribed ZOVIRAX and acyclovir. The patient was seen in the office. It was reported that the patient recovered on an unknown date. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a pharmacist concerning a patient who on 22-JUL-2009 was vaccinated with VARIVAX (Merck) instead of ZOSTAVAX (Merck) (routes and lot numbers unspecified). No symptoms were reported. It was unknown if the patient sought medical attention. No further information is available.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Rash papular, Rash pruritic, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 5 year old male patient who was vaccinated on unspecified date with a second dose of VARIVAX (Merck) SQ, 0.5ml. Physician reported that the patient developed chickenpox after receiving the dose of VARIVAX (Merck). Physician confirmed the rash as being chickenpox. The patient has sought medical attention at office visit. At the time of this report, the patient was recovering. Follow up information has been received from a nurse concerning a 5 year old male patient with decay, otorrhea, tympanic membranal perforation, esophageal reflux and chromosomal anomaly who on 03-OCT-2009 was vaccinated with a second dose of VARIVAX (Merck), IM, left thigh, (previously reported as SC). Concomitant therapy included MMR II (MSD) given IM on the same day. Other concomitant therapy included KINRIX. On 07-OCT-2009 the patient developed chicken pox, no complications, rash itches, no fever, multiple raised red papules, and papulovesicles on left side of face, new papules forming on legs, several facial lesions crossed. A clinical laboratory diagnosis was performed (results unknown). A week later the patient recovered (approximately 14-OCT-2009). Additional information is not expected.
Age: 12.0
Sex: M
Vaccine: VARCEL
Symptoms: Scab, Varicella
Clinical narrative: Information has been received from a physician concerning a 13 year old male patient with no pertinent medical history and no known drug allergies/drug reactions who on 16-JUL-1996 was vaccinated with the first 0.5 mL dose of VARIVAX (Merck) (Lot # 617219/0250D) subcutaneously.  On 08-JAN-2008, the patient received the second 0.5 mL dose of VARIVAX (Merck) (Lot # 659214/1508U) subcutaneously.  There was no concomitant medication reported.  It was reported that on 15-JUL-2009 he came to the office with a mild case of varicella scattered through trunk, neck and groin area.  The physician stated there was no fever or other symptoms.  The physician checked on the patient on 22-JUL-2009 and the lesions were scabbed over.  The vaccine was not reintroduced.  There were no laboratory diagnostic tests performed.  At the time of the report the outcome of the patient was unknown.  No further information is available.
Age: 1.0
Sex: F
Vaccine: HEPA, PNC, VARCEL
Symptoms: Injection site cellulitis
Clinical narrative: Information has been received from a nurse concerning a 12 month old premature baby girl with scoliosis and a history of talipes equinovarus, nutritional deficiency (unspecified), kidney problem, retinopathy, constipation and liver disorder and no known allergies who on 17-FEB-2001 was vaccinated SQ with a 0.5 ml dose of VARIVAX (Merck) (lot number not reported as 0204Y, which is not valid for VARIVAX (Merck), but is a cancidas number). Concomitant therapy included PREVNAR, MIRALAX and hepatitis A virus vaccine (manufacturer unspecified). On 24-FEB-2010 the patient developed a cellulitis type injection site reaction. The patient had no fever. Unspecified medical attention was sought. There was no lab studies performed. At the time of the report, the patient had not recovered. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Headache, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old male who in April, was vaccinated with the second dose of VARIVAX (Merck) and then 7 to 8 days later the patient broke out with a serious varicella rash. The nurse reported that the patient had hundreds of pustules on his body but specially in his mouth and rectum. The nurse reported that she did not remember if she took the patient's temperature but she assume that the patient had one. The patient was given BENADRYL (manufacturer unspecified), TYLENOL WITH CODEINE (manufacturer unspecified" and "Magic mouthwash" (manufacturer unspecified) to help with his varicella rash. The nurse reported that she believed the patient had recovered since the patient never back into the office after that for treatment. Follow up information has been received from a health professional concerning a 4 year old male (previously reported as 5 year old) with no illness at the time of vaccination who on 20-APR-2009, at 2:15 p.m., was vaccinated SC into the left arm with second dose of VARIVAX (Merck) (lot number 660502/0187Y). Eight days after receiving the second dose of VARIVAX (Merck), on 28-APR-2009, the patient experienced severe headache and broke out with chickenpox everywhere. The severe case lasted for several days with mouth lesions. Subsequently, on an unknown date, the patient recovered. Additional information is not expected.
Sex: M
Vaccine: VARCEL
Symptoms: Antibody test negative, No therapeutic response
Clinical narrative: Information has been received from a physician concerning himself who on an unspecified dates was vaccinated with three doses of VARIVAX (Merck) subcutaneously.  It was reported that he was not still showing any immunity.  It was reported that the patient had not recovered at the time of the report.  Additional information has been requested.
Age: 1.3
Sex: M
Vaccine: FLU3, MMR, VARCEL
Symptoms: Immediate post-injection reaction, Injection site erythema, Injection site urticaria
Clinical narrative: Information has been received from a registered nurse concerning a 15 month old female patient with no pertinent medical history or illness at the time of vaccination, who on 03-SEP-2009 was vaccinated in the left thigh with the first dose of VARIVAX (lot # 664905/0865Y). The same day the patient was vaccinated in the right thigh with the first dose of MMR II (lot number 664607/0609Y) (MSD) (WAES0910USA00806). The nurse reported that the patient developed a wheal at the injection site immediately after administration of VARIVAX. The patient was treated with BENADRYL. After 15 minutes the wheal was gone but the area was still red. The patient sought unspecified medical attention. No laboratory diagnostics studies were performed. Follow up information has been received from the registered nurse who reported that on 03-SEP-2009 (same day of VARIVAX) the male patient (previously reported as female) was vaccinated in the left thigh with the third dose of influenza virus vaccine (unspecified) (lot number UT31736A). The reporter stated that immediately post-vaccination, the patient developed a wheal at the injection sites from VARIVAX and MMR II and that patient recovered the same day with BENADRYL. The patient had no other symptoms. This is one of several reports received from the same source. No further information is available.
Age: 0.97
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Information has been received from a consumer concerning her daughter an 1 year old female patient with seasonal allergy who in April 2006, was vaccinated SQ with a dose of VARIVAX (Merck) (dose and lot number not reported).  The consumer reported that the patient broke out with blister like a rash in 2006.  The patient recovered but then she broke out again in 2009.   Both cases were "mild".  At the time of the report the outcome of the adverse events in 2009 were unknown.  The patient did not seek medical attention.
Age: 5.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site urticaria
Clinical narrative: Information has been received from a consumer concerning her daughter with allergies to corn, dairy soy and no reported medical history, who was vaccinated in "August 2005" (day unspecified) with the first dose of VARIVAX (Merck)  (route and lot number unspecified).  The mother reported that her daughter experienced "swelling or a big hive reaction on the injection site" after she received the second dose of VARIVAX (Merck) on 21-JUL-2009 (route and lot number unspecified).  There was no concomitant medication reported.  The mother stated the the patient never had reaction with the first dose of the vaccine.  No laboratory tests were performed.  At the time of the report the outcome was recovering.  The patient sought medical attention by calling the nurse.  Follow up information has been received from a nurse concerning a 5 year old female patient with multiple food allergies and asthma who on 21-JUL-2009 was vaccinated SQ into the right arm with a second dose of VARIVAX (Merck) (lot number : 663330/0493Y).  There was no illness at the time of vaccination.  On 22-JUL-2009, the patient developed a half dollar size area of redness.  The nurse reported that she gave her home care advice was given with instructions to see provided in 24 hours.  However the patient did not follow through.  At the time of the report the outcome of the patient was unknown.  Additional information has been requested.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning an 11 year old female with no medical history or drugs allergies, who on 24-NOV-1998 was vaccinated with a 0.5 mL first dose of VARIVAX (Merck) (lot # 628147/1262H), subcutaneously.  The patient received a second dose of VARIVAX (Merck) (lot # 658286/1096U) on 18-JUL-2009 in her left arm.  There were no concomitant medication.  On 18-JUL-2009 the patient developed chicken pox with less than 50 lesions present.  No laboratories studies performed.  The patient sought medical attention through a phone call.  At the time of this report the patient was recovering.  Follow-up information was received from the registered nurse who reported that the female patient received 2 doses of VARIVAX (Merck) and still contracted varicella disease.  At the time of reporting, the patient had recovered.  No further information is available.
Age: 1.0
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a health professional concerning an approximately 11 year old patient who on 25-SEP-1997 was vaccinated with a dose of VARIVAX (Merck) (lot#, route and site of administration not reported). On approximately 06-MAY-2008 the patient developed few lesions. At the time of reporting, the patient's outcome was unknown. This is one of several reports from the same source. No further information is available.
Age: 1.02
Sex: U
Vaccine: VARCEL
Symptoms: Blister
Clinical narrative: Information has been received from a licensed practical nurse concerning an approximately 12 year old patient who on 19-FEB-1997 was vaccinated with a dose of VARIVAX (Merck) (lot #, route and site of administration not reported).  On approximately 13-MAY-2008 the patient developed some vesicle scattered.  At the time of the reporting, the patient's outcome was unknown.  This is one of several reports from the same source.  No further information is available.
Age: 4.0
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a health professional concerning an approximately 13 year old patient who on 29-DEC-1998 was vaccinated with a dose of VARIVAX (Merck) (lot#, route and site of administration not reported). On approximately 12-MAY-2008 the patient developed 50 lesions. At the time of the reporting, the patient's outcome was unknown. This is one of several reports from the same source. No further information is available.
Age: 7.0
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a health professional concerning an approximately 7 year old patient who was vaccinated with a dose of VARIVAX (Merck) (lot #, route and site of administration not reported).  On approximately 27-MAY-2008 the patient developed 5-10 lesions.  At the time of the reporting, the patient's outcome was unknown.  This is one of several reports from the same source.  No further information is available.
Age: 9.0
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a health professional concerning an approximately 9 year old patient who was was vaccinated with a dose of VARIVAX (lot #, route and site of administration not reported). On approximately 27-MAY-2008 the patient developed 5-10 lesions. At the time of the reporting, the patient's outcome was unknown. This is one of several reports for the same source. No further information is available.
Age: 1.01
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a health professional concerning a 12 month old patient who on 09-MAY-2008 was vaccinated with a dose of VARIVAX (Merck) (lot #, route and site of administration not reported).  On approximately 28-MAY-2008 the patient developed 20-50 lesions.  At the time of the reporting, the patient's outcome was unknown.  This is one of several reports from the same source.  No further information is available.
Sex: F
Vaccine: VARCEL
Symptoms: Laboratory test normal, No therapeutic response
Clinical narrative: Information has been received from a nurse practitioner concerning a female who on 17-NOV-1995 was vaccinated with a dose of VARIVAX (Merck) (LOT # not reported).  This was believed to be the second dose of VARIVAX (Merck) for the patient.  Recently, a titer was done that showed no immunity at all.  Another dose of VARIVAX (Merck) was administered in August 2009.  The patient sought medical attention in an office.  No further information was available at the time of this report.  Additional information has been requested.